Research programme: TRPV1 antagonists - DiverDrugs
Alternative Names: DD 01127Latest Information Update: 16 Jul 2016
At a glance
- Originator DiverDrugs
- Class Non-opioid analgesics; Peptides
- Mechanism of Action TRPV1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer pain; Inflammation; Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer-pain in Spain
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammation in Spain
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in Spain